539
Views
0
CrossRef citations to date
0
Altmetric
Review

Biodegradable Elastomers for Biomedical Applications and Regenerative Medicine

, , , &
Pages 385-398 | Published online: 17 Jun 2014
 

Abstract

Synthetic biodegradable polymers are of great value for the preparation of implants that are required to reside only temporarily in the body. The use of biodegradable polymers obviates the need for a second surgery to remove the implant, which is the case when a nondegradable implant is used. After implantation in the body, biomedical devices may be subjected to degradation and erosion. Understanding the mechanisms of these processes is essential for the development of biomedical devices or implants with a specific function, for example, scaffolds for tissue-engineering applications. For the engineering and regeneration of soft tissues (e.g., blood vessels, cardiac muscle and peripheral nerves), biodegradable polymers are needed that are flexible and elastic. The scaffolds prepared from these polymers should have tuneable degradation properties and should perform well under long-term cyclic deformation conditions. The required polymers, which are either physically or chemically crosslinked biodegradable elastomers, are reviewed in this article.

Financial & competing interests disclosure

E Bat and Z Zhang were financially supported by respectively the Dutch Program for Tissue Engineering (DPTE) and The Netherlands foundation for Scientific Research (NWO). DW Grijpma and J Feijen are co-founders and shareholders of Medisse, a spin-off company of the University of Twente that develops medical implants based on poly(trimethylene carbonate). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

E Bat and Z Zhang were financially supported by respectively the Dutch Program for Tissue Engineering (DPTE) and The Netherlands foundation for Scientific Research (NWO). DW Grijpma and J Feijen are co-founders and shareholders of Medisse, a spin-off company of the University of Twente that develops medical implants based on poly(trimethylene carbonate). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.